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Purpose: The serum protein-binding characteristic of lamotrigine with sera from various species (horse, 
rat, rabbit and goat) was studied at different dielectric constants and temperatures to obtain an insight 
into the mechanism of interaction, evaluate the effect of dielectric constant on binding affinity, and to 
determine the effect of species variation on drug plasma-protein interaction.  
Method: Binding data were generated by evaluating equilibrium dialysis of lamotrigine in methanol-
water solvent (1:1 and 1:3) with horse serum at 20, 28 and 37 
0
C  The equilibrium dialysis evaluation of 
lamotrigine with sera of other animal species - rabbit, goat and rat - was also performed at 37 
0
C. 
Results: A Rosenthal plot obtained with the binding data at different temperatures showed that binding 
constant decreased with increasing temperature and that binding of lamotrigine to horse serum 
appeared to be saturation binding. The results also indicated that the binding process was characterized 
by negative ∆H
0 
value and a small positive ∆S
0
 values. The binding constant decreased as dielectric 
constant rose.  
Conclusions: The results obtained suggest that hydrophobic interaction may have occurred and that 
van der Waals’ forces were responsible for binding in the hydrophobic region. Data obtained for 
lamotrigine binding with horse, goat, rabbit and rat sera show that there are no significant changes in 
plasma protein binding in the above-mentioned species.  
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INTRODUCTION 
 
Protein binding has long been considered 
one of the most important physicochemical 
characteristics of drugs, playing a potential 
role in pharmacokinetic (including hepatic 
metabolism rate, renal excretion, 
biomembrane permeation rate and steady 
state distribution volume) [1-3] and 
pharmacodynamic properties of drugs [4]. 
Plasma protein binding of drug molecules has 
implication in drug safety [5] and several 
adverse effects such as low clearance, low 





It has also been pointed out that not 
only binding equilibrium but also offset rate 
may influence the efficacy/distribution of the 
compound [8]. In our previous works, studies 
were carried out to evaluate the effect of 
concentration, temperature, pH and ionic 
strength
 
on highly albumin-bound drugs and 
bovine serum albumin (BSA) interaction to 
explore protein-binding characteristics of 
some drugs [9,10]. The influence of species 
on plasma protein binding of various drugs 
has also been reported [11-13].  
 
The present study was designed to evaluate 
the effect of drug concentration, temperature 
and dielectric constant on horse serum 
binding of a moderately plasma protein-
bound drug and also to determine the 
influence of the binding of the drug on the 
sera of different animal species. Lamotrigine, 
a phenyltriazine derivative, is as an anti-
seizure drug with a degree of plasma protein 
binding of 56 % [14]. Some thermodynamic 
parameters [15,16]
 
of lamotrigine and horse 
serum were also derived.  The data obtained 
could help in gaining some insight into 




Lamotrigine was obtained from Cadila, 
Ahmedabad, India as a gift. Dialysis tubing 
was purchased from Sigma Chemical 
Company, St. Louis, USA. All other 
chemicals and reagents used were of 
analytical grade.  
The animal experiments were approved by 
the Animal Ethics Committee of Gupta 
College of Technological Sciences, Asansol, 
India (ref no. GCTS/AEC/2007/03) and 
carried out as per the requirements of the 
committee. The animals were housed in 
separate rooms at controlled temperature 
and relative humidity (25 
0
C and 45 %RH) 
and 12 h light/dark cycle for 3 days prior to 
blood collection. The rabbits (3) and rats (12) 
were fed normally with green leafy 
vegetables, milk and soaked Bengal gram 
(for the rabbits) and Nutrilab Rodent
®
 
(Vetcare Div., Tetragon Cheme Pvt Ltd, 
Bangalore, India). They also freely received 
water. Blood was withdrawn with heparinised 
needles from the marginal ear vein of the 
rabbits and the tail vein of the rats. The blood 
was pooled in each case and approximately 
10ml was centrifuged at 3000×g to obtain 
serum which was stored at -20 
0
C till further 
use. Goat blood was collected from local 
slaughter house at Asansol while horse 
serum was kindly provided free of charge by 
Bengal Chemical and Pharmaceuticals, 
Kolkata, India and used as such 
 
Determination of extent of lamotrigine - 
horse serum protein binding 
 
The extent of protein binding of lamotrigine 
with horse serum binding was determined by 
equilibrium dialysis method [17-18]. 
Equilibrium dialysis was chosen for this study 
because of its ability to reasonably 
approximate physiological conditions. The 
drug bound was determined indirectly by 
measuring the unbound drug fraction 
spectrophotometrically at 308 nm (Thermo 
Spectronic UV1, UK.). Dialysis bags were 
prepared from dialysis tube as described in 
literature
 
(after treating according to the 
manufacturer’s instruction) and then soaked 
for 24 h in phosphate buffer solvent (pH 7.4) 
prior to use [19]. The equilibrium dialysis 





 M/L) using 61.5 
µM/L horse serum was performed using 1:3 
methanol-water system. Incubation was for 1, 
4, 8, 20, 24 and 28 h, respectively, at 20 
0
C 
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with continuous stirring at very slow speed. A 
control, containing drug in dialysing medium, 
was run simultaneously to determine loss due 
to membrane binding of drugs in each case. 
Another control without drug was also run to 
determine probable albumin transfer across 
the membrane, by measuring the UV 
absorbance of the solvent at 280 nm to check 
for albumin leakage. In all determinations, the 
horse serum albumin (HSA) concentration 
used was 0.4% w/v, i.e., 61.5 µM/L. The 
unbound drug fraction was measured 
spectrophotometrically at 308 nm. 
 
Effect of drug concentration on in vitro 
horse serum-drug binding  
 
A dialysis bag containing 5 ml of horse serum 
and 2 ml of lamotrigine solution (of various 
concentrations) in 1:3 methanol-water system 
was lowered into 20 ml of 1:3 methanol-water 
dialyzing solution. The dialysis procedure 
was performed for 20 h with continuous 
stirring at very slow speed at 20, 28 and 37 
0
C. In all determinations, HSA concentration 
used was 0.4 %w/v, i.e., 61.5 µM/L. All 
control studies were also performed as 
described above. The bound lamotrigine was 
detected indirectly by measuring the unbound 
fraction of lamotrigine at 308 nm. 
 
Effect of dielectric constant on 
lamotrigine - HSA binding  
 
Equilibrium dialysis of different 
concentrations of lamotrigine with has at 
different dielectric contants was also 
evaluated using 1:3 methanol-water and 1:1 
methanol-water solvent systems at 20 
0
C. 
Other conditions were constant. All control 
studies were similarly performed as 
described above. The bound lamotrigine was 
detected indirectly by measuring its unbound 
fraction at 308 nm.  Protein binding (%) was 
calculated from Eq. 1. 
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Binding equilibrium  
 
The results of the experiments to determine 
the amount of lamotrigine bound to horse 
serum protein at various times indicate that 
the minimum binding time requirement to 
reach equilibrium was 20 h (Fig 1). Based on 
these results, all equilibrium dialysis studies 
were performed for 20 h. From the results of 
the control studies, it was observed that not 
more than 1.6 % drug was bound with the 
membrane and the limit of detection of 
albumin leakage by this method was 0.03 % 
albumin. Both of these correction factors 




















Fig 1:  Binding of lamotrigine to horse serum at 
different time intervals at 20 
0
C. (Key:  , drug 
conc. = 0.17 µmol/L;  ■, drug conc. 5.25 µmol/L) 
 
Binding characteristics of lamotrigine with 
horse serum protein 
 
The equilibrium dialysis study data for the 
binding of lamotrigine to horse serum at three 
different temperatures were analyzed using 
Graph Pad Prism 3-version software to 
perform a regression for Rosenthal plot [20] 
which is expressed in Eqs. 2 - 4:  
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where  ‘Bound’ and ‘Free’ means bound and 
free drug concentrations, respectively,  after 
equilibration with protein; Kd is the 
dissociation constant; and Bmax is saturation 
binding. 
 
This is an equation for a straight line (Y = c - 
mX) which was first derived by Rosenthal, 
where Y = Bound/Free and X = Bound. The 
Rosenthal plot obtained using the equilibrium 
dialysis study data for the binding of 
lamotrigine to horse serum protein (HSA) at 
three different temperatures is shown in Fig 
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Fig 2: Lamotrigine-horse serum protein interaction 
at different temperatures in methanol: water (1:3) 
solvent system.  (Key:  Db =  bound drug; Df = 
free drug;  ■ = 20 
0
C;  = 28 
0




trigine to HSA is a saturation-binding 
phenomenon. The bound fraction decreased 
with increasing drug concentration, and 
binding occurred more with the unionised 
drug. The dialysis medium used was 1:3 
methanol-water system. The binding constant 
decreased with increasing temperature. To 
determine the effect of dielectric constant of 
the dialysis medium on the binding affinity, 
the binding studies were performed in two 
different solvent systems, viz, 1:3 methanol-
water and 1:1 methanol-water. The results 
are shown in Fig 3. Decreasing dielectric 
constant resulted in a fall in polarity and 
increased the affinity of the drug to the 
solvent. The best fit linear regression 















Fig 3: Lamotrigine-horse serum protein interaction 
at 20 
0
C in two solvent systems (Key: DB = bound 
drug; DF = free drug; ♦ = 1:3 methanol-water; and 

















































=0.9223,   P< 0.0001) 
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where bD and fD  are bound and free drugs, 
respectively. The calculated values of Bmax, 
Kass (association constant = 1/Kd) and 
standard free energy change are reported in 
Table 1.  
 
Table 1:  Binding of lamotrigine with horse serum 



































1963 46.57 -4.43 
 
 
Binding of lamotrigine with various animal 
sera  
 
Table 2 shows the results of the interaction of 
lamotrigine with the sera of horse, goat, 
rabbit and rat.  We observed that the extent 
of serum protein binding of lamotrigine with 
different species is within 47 – 51 % at low 
concentration of lamotrigine but it is within 
39-41% at higher concentration. 
 
Table 2: Binding of lamotrigine with serum 
proteins of various animal species at 37 
0
C, pH 7.4 


















drug    
(%) 
6.2 0.051 0.102 50.0 Horse 
24.2 0.265 0.45 41.1 
6.2 0.052 0.102 49.02 Rat 
24.2 0.270 0.45 40.0 
6.2 0.523 0.102 48.72 Rabbit 
24.2 0.2693 0.45 40.2 
6.2 0.054 0.102 47.1 Goat 
24.2 0.274 0.45 39.1 
  





The principle of protein binding is that when a 
drug and protein are initially mixed together, 
the amount of drug-protein complex formed 
will exceed the dissociation of the drug-
protein complex [21]. Subsequently, the 
system reaches equilibrium, following which 
maximum drug protein interaction will occur. 
Therefore, the time taken to reach equilibrium 
is an important factor in equilibrium dialysis. 
In this work, the equilibrium time was found to 
be 20 h and hence this was the time used in 
all the evaluations. 
 
Thermodynamic analysis and mechanism 
of interaction   
 
Assuming that there was no significant 
temperature dependence of enthalpy change 
within the temperature range in which the 
interaction was carried out, the standard free 
energy change (∆G
0
), the standard enthalpy 
change (∆H
0
) and the standard entropy 
change (∆S
0
) for drug-protein binding were 
obtained from van’t Hoff plot (not shown) 




  = − 2.303 RT log K   ………………..    (9) 




  /2.303R… (10) 
 





standard entropy change, ∆S
0
, can also be 
obtained from the above relationship. A best-
fit linear plot of log K vs. 1/T (van’t Hoff plot) 
for primary binding site was made (see Fig 4) 
and the regression equation obtained is 
shown in Eq 11.   
 
Log K = 303.13/T+ 2.3715 ……………….   (11) 
(R
2
 = 0.997)     
             




 for primary 
binding site were obtained from the slope and 







 were – 4.65 Kcal/mol 
(mean calculated from Table 1), –1.38 
Kcal/mol, and 10.81 cal/mol deg, 
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respectively.  The decrease in the association 
constant of lamotrigine - horse serum 
interaction process with increasing 
temperature shows that the binding was an 
exothermic reaction and the negative sign for 
∆G
0
 means that the binding process was 
spontaneous. A high negative ∆H
0 
value 
indicates the absence of electrostatic 
interaction between drug and protein 
molecules [16, 22]. The positive value of ∆S
0
 
associated with many reactions involving 
proteins is usually attributed to disorientation 
and unfolding of the protein molecule. The 
moderately high negative value of enthalpy 
change observed in this work shows that this 
is not a satisfactory explanation. Rather a 
small positive ∆S
0
 suggests that hydrophobic 
interaction [23] may be responsible and that 
van der Waals forces [24] are involved in 
binding in the hydrophobic region [25-26].  
 
Effect of dielectric constant on 
lamotrigine - horse serum protein binding 
 
Decrease in dielectric constant of the binding 
medium lowered the intrinsic binding affinity 
between lamotrigine and horse serum. The 
effect of solvent on drug-protein binding has 
been estimated by various researchers [27-
29]. Decrease in binding constant with 
decrease in dielectric constant (ε = 55.6 for 
1:1 methanol-water system compared to ε = 
67 for 1:3 methanol-water system) may be 
attributed to the fact that the drug is less 
polar than water. Thus, their affinity to the 
medium would increase as dielectric constant 
decreases. This observation indicates that 
hydrophobic interaction was the major force 
in the binding of lamotrigine with horse serum 
protein [30]. 
 
Binding of lamotrigine with other animal 
sera 
 
The interaction of lamotrigine with the 
proteins of horse, goat, rabbit and rat sera did 
not vary significantly, thus indicating that 
protein binding with the drug in the sera of 
the animal species was similar.  
 
CONCLUSION  
Protein binding of the moderately serum 
protein-bound drug, lamotrigine, was 
dependent on temperature and the dielectric 
constant of the solvent medium. The 
mechanism of binding was mainly due to 
hydrophobic interaction arising from van der 
Waals forces as evident in the fact that 
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